Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium ascorbate,cupric sulfate pentahydrate,citrus bioflavonoids extract,magnesium aspartate dihydrate,olea europaea,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium ascorbate,citrus bioflavonoids extract,cupric sulfate pentahydrate,magnesium aspartate dihydrate,olea europaea,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium ascorbate dihydrate,cupric sulfate pentahydrate,citrus bioflavonoids extract,magnesium aspartate dihydrate,olea europaea,zinc sulfate monohydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - zinc sulfate monohydrate, quantity: 68.61 mg (equivalent: zinc, qty 25 mg); citrus bioflavonoids extract, quantity: 20 mg; olea europaea, quantity: 55.56 mg (equivalent: olea europaea, qty 250 mg); magnesium aspartate dihydrate, quantity: 250 mg (equivalent: magnesium, qty 18.75 mg); cupric sulfate pentahydrate, quantity: 3.93 mg (equivalent: cupric sulfate, qty 2.51 mg; equivalent: copper, qty 1 mg); calcium ascorbate dihydrate, quantity: 605.34 mg (equivalent: ascorbic acid, qty 500 mg) - tablet, film coated - excipient ingredients: carnauba wax; maltodextrin; magnesium stearate; povidone; colloidal anhydrous silica; tartaric acid; spearmint oil; hypromellose; croscarmellose sodium; titanium dioxide; iron oxide yellow; macrogol 400; microcrystalline cellulose - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; maintain/support general health and wellbeing ; maintain/support immune system health ; enhance/improve/promote immune defence/immunity ; maintain/support healthy immune system function ; maintain/support immune system to fight illness ; helps stimulate a healthy immune system response ; support healthy stress response in the body ; decrease/reduce/relieve common cold duration ; decrease/reduce/relieve the severity of common cold symptoms ; decrease/reduce/relieve symptoms of common cold

Australia - English - Department of Health (Therapeutic Goods Administration)

swisse wellness pty ltd - calcium ascorbate dihydrate, quantity: 493.61 mg (equivalent: ascorbic acid, qty 445.53 mg; equivalent: calcium, qty 50.7 mg); olea europaea, quantity: 55.56 mg (equivalent: olea europaea, qty 250 mg; equivalent: oleuropein, qty 11.1 mg); cupric sulfate pentahydrate, quantity: 3.5 mg (equivalent: copper, qty 891 microgram; equivalent: cupric sulfate, qty 2.24 mg); citrus bioflavonoids extract, quantity: 20 mg; zinc sulfate monohydrate, quantity: 18.52 mg (equivalent: zinc, qty 6.75 mg); magnesium aspartate - tablet, film coated - excipient ingredients: iron oxide yellow; titanium dioxide; tartaric acid; croscarmellose sodium; spearmint oil; maltodextrin; macrogol 400; colloidal anhydrous silica; carnauba wax; microcrystalline cellulose; hypromellose; povidone; magnesium stearate - antioxidant/reduce free radicals formed in the body ; helps reduce/decrease free radical damage to body cells ; helps enhance/promote general health and wellbeing

United States - English - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c: calcium acetate capsules contains calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)] . maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown.

United States - English - NLM (National Library of Medicine)

camber pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate tablets contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unknown. a c

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and d

United States - English - NLM (National Library of Medicine)

lupin pharmaceuticals, inc. - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1)]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are unk

United States - English - NLM (National Library of Medicine)

lupin limited - calcium acetate (unii: y882yxf34x) (calcium cation - unii:2m83c4r6zb) - calcium acetate 667 mg - calcium acetate capsule is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (esrd). patients with hypercalcemia. pregnancy category c calcium acetate capsules contain calcium acetate. animal reproduction studies have not been conducted with calcium acetate, and there are no adequate and well controlled studies of calcium acetate use in pregnant women. patients with end stage renal disease may develop hypercalcemia with calcium acetate treatment [see warnings and precautions (5.1) ]. maintenance of normal serum calcium levels is important for maternal and fetal well being. hypercalcemia during pregnancy may increase the risk for maternal and neonatal complications such as stillbirth, preterm delivery, and neonatal hypocalcemia and hypoparathyroidism. calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment. the effects of calcium acetate on labor and delivery are un